⌕
Material Group
| material id | material description | material group | standard price | severity | signal count | finding count | worst severity | signals flagged | health score | net exposure chf | polarity | risk score | direction | avg io coefficient | total transfer qty | total usage qty | total qty delta | months active | window from | window to | window label | raw money at risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ∑ CHF 579'580.03 | ∑ 78'215 | ∑ 2'309'566 | ∑ 26'461.347 | ∑ CHF-29'961'232.42 | ∑ 1'510'680 | ∑ 32'008.349 | ∑ 2'935'484 | ∑ 1'634'412 | ∑ -1'301'072 | ∑ 339'468 | ||||||||||||
| 0001 ◈◉ | Tranexamsäure 5mg/5ml | MEDICATION_MAT | CHF 10.79 | medium | 1 | 1 | medium | signal_io_coefficient_trend | 0.818 | CHF 593.45 | over_billing | 100 | improving | 7.111 | 9 | 64 | 55 | 12 | 2025-10 | 2026-09 | 2025-10 – 2026-09 | — |
| 0002 ◈◉ | Gelofusin 500ml | MEDICATION_MAT | CHF 3.73 | high | 3 | 121 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 67.14 | balanced | 50 | worsening | 1.5 | 36 | 54 | 18 | 12 | 2025-10 | 2026-10 | 2025-10 – 2026-10 | — |
| 0003 ◈◉ | Ringer-Laktat 1000ml | MEDICATION_MAT | CHF 5.44 | high | 3 | 139 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF-614.72 | leakage | 59.5 | worsening | 0.405 | 190 | 77 | -113 | 12 | 2025-06 | 2026-11 | 2025-06 – 2026-11 | — |
| 0004 ◈◉ | Hämostatikum 20ml | MEDICATION_MAT | CHF 5.19 | medium | 1 | 75 | high | signal_negative_margin | 0.818 | CHF-108.99 | leakage | 22.8 | worsening | 0.772 | 92 | 71 | -21 | 12 | 2025-08 | 2026-10 | 2025-08 – 2026-10 | — |
| 0005 ◈◉ | Cefazolin 2mg/ml | MEDICATION_MAT | CHF 11.30 | medium | 1 | 1 | medium | signal_io_coefficient | 0.727 | CHF 169.50 | over_billing | 26.3 | worsening | 1.263 | 57 | 72 | 15 | 12 | 2025-10 | 2026-10 | 2025-10 – 2026-10 | — |
| 0006 ◈◉ | Fibrinkleber 20ml | MEDICATION_MAT | CHF 34.64 | medium | 2 | 64 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 2'147.68 | over_billing | 100 | improving | 4.647 | 17 | 79 | 62 | 12 | 2025-06 | 2026-08 | 2025-06 – 2026-08 | — |
| 0008 ◈◉ | Vancomycin 50mg/5ml | MEDICATION_MAT | CHF 2.03 | high | 3 | 115 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 178.64 | over_billing | 100 | stable | 30.333 | 3 | 91 | 88 | 12 | 2025-07 | 2026-11 | 2025-07 – 2026-11 | — |
| 0009 ◈◉ | Cefazolin 10mg/10ml | MEDICATION_MAT | CHF 3.12 | medium | 2 | 62 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 49.92 | balanced | 23.2 | improving | 1.232 | 69 | 85 | 16 | 12 | 2025-08 | 2026-10 | 2025-08 – 2026-10 | — |
| 0010 ◈◉ | Kontrastmittel Iohexol 10ml | MEDICATION_MAT | CHF 1.03 | medium | 2 | 68 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF 42.23 | balanced | 85.4 | worsening | 1.854 | 48 | 89 | 41 | 12 | 2025-07 | 2026-07 | 2025-07 – 2026-07 | — |
| 0011 ◈◉ | Lidocain 50mg/5ml | MEDICATION_MAT | CHF 2.28 | medium | 2 | 74 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 38.76 | balanced | 24.3 | improving | 1.243 | 70 | 87 | 17 | 12 | 2025-08 | 2027-01 | 2025-08 – 2027-01 | — |
| 0012 ◈◉ | Ringer-Laktat 250ml | MEDICATION_MAT | CHF 10.10 | medium | 3 | 139 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.455 | CHF-494.90 | leakage | 39.5 | improving | 0.605 | 124 | 75 | -49 | 12 | 2025-11 | 2027-01 | 2025-11 – 2027-01 | — |
| 0013 ◈◉ | Knochenzement 40g | MEDICATION_MAT | CHF 2.35 | high | 3 | 120 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 103.40 | over_billing | 100 | worsening | 2.257 | 35 | 79 | 44 | 12 | 2025-05 | 2026-07 | 2025-05 – 2026-07 | — |
| 0014 ◈◉ | Atropin 2mg/ml | MEDICATION_MAT | CHF 49.43 | high | 3 | 125 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF-4'646.42 | leakage | 64.8 | worsening | 0.352 | 145 | 51 | -94 | 12 | 2025-07 | 2026-07 | 2025-07 – 2026-07 | — |
| 0015 ◈◉ | Kontrastmittel Iohexol 5ml | MEDICATION_MAT | CHF 3.26 | medium | 2 | 80 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF 234.72 | over_billing | 0 | worsening | — | 0 | 72 | 72 | 12 | 2025-09 | 2026-11 | 2025-09 – 2026-11 | — |
| 0016 ◈◉ | Glucose 5% 1000ml | MEDICATION_MAT | CHF 22.12 | medium | 2 | 66 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 442.40 | over_billing | 35.1 | improving | 1.351 | 57 | 77 | 20 | 12 | 2025-10 | 2027-03 | 2025-10 – 2027-03 | — |
| 0017 ◈◉ | Bupivacain 500mg | MEDICATION_MAT | CHF 29.53 | medium | 2 | 148 | high | signal_billing_below_internal_price, signal_negative_margin | 0.636 | CHF 2'391.93 | over_billing | 100 | improving | 11.125 | 8 | 89 | 81 | 12 | 2025-10 | 2026-10 | 2025-10 – 2026-10 | — |
| 0018 ◈◉ | NaCl 0.9% 250ml | MEDICATION_MAT | CHF 10.18 | medium | 2 | 68 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF-356.30 | leakage | 28.5 | improving | 0.715 | 123 | 88 | -35 | 12 | 2025-09 | 2026-11 | 2025-09 – 2026-11 | — |
| 0020 ◈◉ | Bupivacain 50mg/5ml | MEDICATION_MAT | CHF 84.05 | medium | 1 | 64 | low | signal_billing_below_internal_price | 0.818 | CHF-4'034.40 | leakage | 41 | improving | 0.59 | 117 | 69 | -48 | 12 | 2025-09 | 2026-10 | 2025-09 – 2026-10 | — |
| 0022 ◈◉ | HES 1000ml | MEDICATION_MAT | CHF 87.82 | medium | 2 | 66 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF-14'139.02 | leakage | 70.9 | worsening | 0.291 | 227 | 66 | -161 | 12 | 2025-07 | 2026-09 | 2025-07 – 2026-09 | — |
| 0023 ◈◉ | Fibrinkleber 10ml | MEDICATION_MAT | CHF 13.22 | medium | 1 | 1 | medium | signal_io_coefficient | 0.727 | CHF 1'070.82 | over_billing | 100 | worsening | 3.7 | 30 | 111 | 81 | 12 | 2025-05 | 2026-09 | 2025-05 – 2026-09 | — |
| 0024 ◈◉ | Cefazolin 500mg | MEDICATION_MAT | CHF 1.78 | medium | 1 | 1 | medium | signal_io_coefficient | 0.727 | CHF 44.50 | balanced | 83.3 | worsening | 1.833 | 30 | 55 | 25 | 12 | 2025-08 | 2026-11 | 2025-08 – 2026-11 | — |
| 0025 ◈◉ | — | — | — | low | 2 | 138 | high | signal_billing_below_internal_price, signal_negative_margin | 0.636 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 0026 ◈◉ | Ketorolac 500mg | MEDICATION_MAT | CHF 10.14 | medium | 2 | 72 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 476.58 | over_billing | 100 | stable | 2.022 | 46 | 93 | 47 | 12 | 2025-12 | 2027-02 | 2025-12 – 2027-02 | — |
| 0027 ◈◉ | Glucose 5% 500ml | MEDICATION_MAT | CHF 41.88 | medium | 2 | 69 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF-1'088.88 | leakage | 28.9 | worsening | 0.711 | 90 | 64 | -26 | 12 | 2025-06 | 2026-08 | 2025-06 – 2026-08 | — |
| 0029 ◈◉ | HES 250ml | MEDICATION_MAT | CHF 2.08 | medium | 2 | 64 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 135.20 | over_billing | 100 | stable | 6.909 | 11 | 76 | 65 | 12 | 2025-10 | 2026-09 | 2025-10 – 2026-09 | — |
| 0030 ◈◉ | Cefazolin 200mg/20ml | MEDICATION_MAT | CHF 48.21 | high | 3 | 139 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 144.63 | over_billing | 3.7 | stable | 1.037 | 81 | 84 | 3 | 12 | 2025-08 | 2027-01 | 2025-08 – 2027-01 | — |
| 0031 ◈◉ | Fibrinkleber 40g | MEDICATION_MAT | CHF 1.09 | medium | 1 | 74 | high | signal_negative_margin | 0.818 | CHF 88.29 | balanced | 100 | stable | 10 | 9 | 90 | 81 | 12 | 2025-10 | 2026-12 | 2025-10 – 2026-12 | — |
| 0032 ◈◉ | Knochenzement 20ml | MEDICATION_MAT | CHF 3.71 | low | 1 | 77 | low | signal_billing_below_internal_price | 0.818 | CHF-126.14 | leakage | 33 | improving | 0.67 | 103 | 69 | -34 | 12 | 2025-11 | 2026-12 | 2025-11 – 2026-12 | — |
| 0033 ◈◉ | Ringer-Laktat 500ml | MEDICATION_MAT | CHF 24.25 | high | 4 | 130 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.182 | CHF 1'770.25 | over_billing | 100 | worsening | 4.042 | 24 | 97 | 73 | 12 | 2025-09 | 2026-09 | 2025-09 – 2026-09 | — |
| 0034 ◈◉ | Tranexamsäure 1mg/ml | MEDICATION_MAT | CHF 72.65 | medium | 2 | 77 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF 145.30 | over_billing | 2.9 | stable | 1.029 | 69 | 71 | 2 | 12 | 2025-08 | 2026-07 | 2025-08 – 2026-07 | — |
| 0036 ◈◉ | Glucose 5% 250ml | MEDICATION_MAT | CHF 2.15 | low | 1 | 59 | low | signal_billing_below_internal_price | 0.818 | CHF-101.05 | leakage | 43.1 | improving | 0.569 | 109 | 62 | -47 | 12 | 2025-06 | 2026-11 | 2025-06 – 2026-11 | — |
| 0037 ◈◉ | Ketorolac 10mg/10ml | MEDICATION_MAT | CHF 2.29 | medium | 2 | 57 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF 164.88 | over_billing | 100 | worsening | 7 | 12 | 84 | 72 | 12 | 2025-09 | 2027-01 | 2025-09 – 2027-01 | — |
| 0038 ◈◉ | Fentanyl 500mg | MEDICATION_MAT | CHF 4.23 | high | 3 | 147 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 25.38 | balanced | 10.9 | stable | 1.109 | 55 | 61 | 6 | 12 | 2025-08 | 2026-12 | 2025-08 – 2026-12 | — |
| 0039 ◈◉ | Midazolam 100mcg/2ml | MEDICATION_MAT | CHF 2.16 | medium | 2 | 60 | medium | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF 62.64 | balanced | 100 | worsening | 2 | 29 | 58 | 29 | 12 | 2025-07 | 2026-08 | 2025-07 – 2026-08 | — |
| 0040 ◈◉ | Atropin 200mg/20ml | MEDICATION_MAT | CHF 4.97 | low | 1 | 65 | low | signal_billing_below_internal_price | 0.818 | CHF-94.43 | balanced | 20.9 | improving | 0.791 | 91 | 72 | -19 | 12 | 2025-08 | 2027-02 | 2025-08 – 2027-02 | — |
| 0041 ◈◉ | Ondansetron 500mg | MEDICATION_MAT | CHF 7.75 | medium | 2 | 70 | high | signal_io_coefficient, signal_negative_margin | 0.546 | CHF 341.00 | over_billing | 100 | worsening | 2.158 | 38 | 82 | 44 | 12 | 2025-07 | 2026-10 | 2025-07 – 2026-10 | — |
| 0042 ◈◉ | — | — | — | low | 1 | 66 | low | signal_billing_below_internal_price | 0.818 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 0043 ◈◉ | Sevofluran 1g Vial | MEDICATION_MAT | CHF 1.92 | medium | 3 | 151 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.455 | CHF 57.60 | balanced | 46.9 | improving | 1.469 | 64 | 94 | 30 | 12 | 2025-08 | 2026-08 | 2025-08 – 2026-08 | — |
| 0044 ◈◉ | Knochenzement 10ml | MEDICATION_MAT | CHF 34.89 | high | 3 | 121 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF-1'186.26 | leakage | 31.8 | improving | 0.682 | 107 | 73 | -34 | 12 | 2025-09 | 2026-11 | 2025-09 – 2026-11 | — |
| 0046 ◈◉ | Hämostatikum 5ml | MEDICATION_MAT | CHF 2.00 | medium | 1 | 73 | high | signal_negative_margin | 0.818 | CHF 30.00 | balanced | 22.4 | worsening | 1.224 | 67 | 82 | 15 | 12 | 2025-09 | 2026-12 | 2025-09 – 2026-12 | — |
| 0048 ◈◉ | Dexamethason 2mg/ml | MEDICATION_MAT | CHF 39.94 | medium | 1 | 1 | medium | signal_io_coefficient | 0.727 | CHF-918.62 | leakage | 28.4 | improving | 0.716 | 81 | 58 | -23 | 12 | 2025-07 | 2027-01 | 2025-07 – 2027-01 | — |
| 0049 ◈◉ | Kontrastmittel Iohexol 20ml | MEDICATION_MAT | CHF 30.62 | medium | 2 | 128 | high | signal_billing_below_internal_price, signal_negative_margin | 0.636 | CHF 796.12 | over_billing | 65 | worsening | 1.65 | 40 | 66 | 26 | 12 | 2025-07 | 2026-07 | 2025-07 – 2026-07 | — |
| 0050 ◈◉ | Adrenalin 200mg/20ml | MEDICATION_MAT | CHF 58.68 | medium | 1 | 1 | medium | signal_io_coefficient | 0.727 | CHF-117.36 | leakage | 2.9 | improving | 0.971 | 69 | 67 | -2 | 12 | 2025-08 | 2026-08 | 2025-08 – 2026-08 | — |
| 0051 ◈◉ | — | — | — | low | 2 | 130 | high | signal_billing_below_internal_price, signal_negative_margin | 0.636 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 0052 ◈◉ | Adrenalin 1g Vial | MEDICATION_MAT | CHF 1.95 | medium | 1 | 1 | high | signal_io_coefficient | 0.727 | CHF 44.85 | balanced | 46.9 | worsening | 1.469 | 49 | 72 | 23 | 12 | 2025-11 | 2027-03 | 2025-11 – 2027-03 | — |
| 0053 ◈◉ | Hämostatikum 10ml | MEDICATION_MAT | CHF 23.49 | medium | 2 | 160 | high | signal_billing_below_internal_price, signal_negative_margin | 0.636 | CHF 1'174.50 | over_billing | 100 | stable | 2.429 | 35 | 85 | 50 | 12 | 2025-08 | 2026-07 | 2025-08 – 2026-07 | — |
| 0054 ◈◉ | — | — | — | low | 1 | 73 | high | signal_negative_margin | 0.818 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 0055 ◈◉ | Ketorolac 5mg/5ml | MEDICATION_MAT | CHF 3.43 | medium | 2 | 70 | high | signal_billing_below_internal_price, signal_io_coefficient | 0.546 | CHF-150.92 | leakage | 36.7 | improving | 0.633 | 120 | 76 | -44 | 12 | 2025-09 | 2026-10 | 2025-09 – 2026-10 | — |
| 0056 ◈◉ | Ondansetron 5mg/5ml | MEDICATION_MAT | CHF 5.03 | low | 1 | 65 | low | signal_billing_below_internal_price | 0.818 | CHF 135.81 | over_billing | 57.4 | worsening | 1.575 | 47 | 74 | 27 | 12 | 2025-07 | 2026-07 | 2025-07 – 2026-07 | — |
| 0057 ◈◉ | Morphin 1mg/ml | MEDICATION_MAT | CHF 16.70 | high | 3 | 127 | high | signal_billing_below_internal_price, signal_io_coefficien... | 0.364 | CHF 684.70 | over_billing | 97.6 | improving | 1.976 | 42 | 83 | 41 | 12 | 2025-05 | 2026-08 | 2025-05 – 2026-08 | — |